-
Je něco špatně v tomto záznamu ?
New hybrid procedures in treating occluded arteriovenous hemodialysis grafts
P. Bachleda, J. Janeckova, P. Xinopulos, O. Smakal
Jazyk angličtina Země Česko
Typ dokumentu časopisecké články, práce podpořená grantem
Grantová podpora
NT14361
MZ0
CEP - Centrální evidence projektů
Digitální knihovna NLK
Plný text - Článek
Zdroj
NLK
Directory of Open Access Journals
od 2001
Free Medical Journals
od 1998
Medline Complete (EBSCOhost)
od 2007-06-01
ROAD: Directory of Open Access Scholarly Resources
od 2001
PubMed
26847419
DOI
10.5507/bp.2015.068
Knihovny.cz E-zdroje
- MeSH
- cévní přístupy škodlivé účinky MeSH
- dialýza ledvin * MeSH
- lidé MeSH
- magnetická rezonanční angiografie MeSH
- okluze cévního štěpu chirurgie MeSH
- přežívání štěpu MeSH
- průchodnost cév MeSH
- stenty MeSH
- trombektomie metody MeSH
- trombóza chirurgie MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
BACKROUND: The use of arteriovenous graft is indicated in patients if the subcutaneous venous bed is exhausted or unsuitable for arteriovenous fistula creation. The leading cause of failure of a prosthetic arteriovenous hemodialysis-access graft is venous anastomotic stenosis causing thrombosis of the graft. A number of surgical techniques and endovascular tools have been used to treat this stenosis and thrombosis. None have yet proven to be ideal. This study was designed to evaluate the results of hybrid treatment of arteriovenous graft thrombosis associated with venous anastomotic stenosis. METHODS: Over the period 2013-2014, we treated 16 AVG occlusions. Immediately after the diagnosis of occlusion was made, the patients underwent thrombectomy using a Fogarty catheter. After thrombectomy, a diagnostic fistulogram was performed and if VAG stenosis was confirmed, it was treated with balloon angioplasty and stent graft introduction. Lesions were dilated to reduce the stenosis in the treated area to less than 25%. RESULTS: Primary patency after 12 months was 32.8%. Primary assisted patency was 44.7%, secondary patency was 47.6%. Restenosis of the stent graft was seen in two patients. Recurring AVG occlusion was observed in four patients. The average number of interventions to maintain AVG patency was 1.18 per patient/1 year of dialysis. CONCLUSION: Treatment of AVG thrombosis due to VAG stenosis by hybrid procedure proved to be effective and improved secondary patency.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc17006135
- 003
- CZ-PrNML
- 005
- 20190104133526.0
- 007
- ta
- 008
- 170210s2016 xr ad f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.5507/bp.2015.068 $2 doi
- 035 __
- $a (PubMed)26847419
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xr
- 100 1_
- $a Bachleda, Petr, $u Department of Surgery II - Vascular and Transplantation Surgery, University Hospital Olomouc, Czech Republic $d 1954- $7 jn20020716344
- 245 10
- $a New hybrid procedures in treating occluded arteriovenous hemodialysis grafts / $c P. Bachleda, J. Janeckova, P. Xinopulos, O. Smakal
- 520 9_
- $a BACKROUND: The use of arteriovenous graft is indicated in patients if the subcutaneous venous bed is exhausted or unsuitable for arteriovenous fistula creation. The leading cause of failure of a prosthetic arteriovenous hemodialysis-access graft is venous anastomotic stenosis causing thrombosis of the graft. A number of surgical techniques and endovascular tools have been used to treat this stenosis and thrombosis. None have yet proven to be ideal. This study was designed to evaluate the results of hybrid treatment of arteriovenous graft thrombosis associated with venous anastomotic stenosis. METHODS: Over the period 2013-2014, we treated 16 AVG occlusions. Immediately after the diagnosis of occlusion was made, the patients underwent thrombectomy using a Fogarty catheter. After thrombectomy, a diagnostic fistulogram was performed and if VAG stenosis was confirmed, it was treated with balloon angioplasty and stent graft introduction. Lesions were dilated to reduce the stenosis in the treated area to less than 25%. RESULTS: Primary patency after 12 months was 32.8%. Primary assisted patency was 44.7%, secondary patency was 47.6%. Restenosis of the stent graft was seen in two patients. Recurring AVG occlusion was observed in four patients. The average number of interventions to maintain AVG patency was 1.18 per patient/1 year of dialysis. CONCLUSION: Treatment of AVG thrombosis due to VAG stenosis by hybrid procedure proved to be effective and improved secondary patency.
- 650 _2
- $a okluze cévního štěpu $x chirurgie $7 D006083
- 650 _2
- $a přežívání štěpu $7 D006085
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a magnetická rezonanční angiografie $7 D018810
- 650 12
- $a dialýza ledvin $7 D006435
- 650 _2
- $a stenty $7 D015607
- 650 _2
- $a trombektomie $x metody $7 D017131
- 650 _2
- $a trombóza $x chirurgie $7 D013927
- 650 _2
- $a cévní přístupy $x škodlivé účinky $7 D062666
- 650 _2
- $a průchodnost cév $7 D014654
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Janečková, Jana, $d 1982- $u Department of Surgery II - Vascular and Transplantation Surgery, University Hospital Olomouc, Czech Republic $7 xx0227477
- 700 1_
- $a Xinopulos, Pavel $u Department of Surgery II - Vascular and Transplantation Surgery, University Hospital Olomouc, Czech Republic $7 xx0252532
- 700 1_
- $a Šmakal, Oldřich $u Department of Urology, University Hospital Olomouc, Czech Republic $7 xx0140221
- 773 0_
- $w MED00012606 $t Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czech Republic $x 1213-8118 $g Roč. 160, č. 1 (2016), s. 149-152
- 910 __
- $a ABA008 $b A 1502 $c 958 $y 4 $z 0
- 990 __
- $a 20170210 $b ABA008
- 991 __
- $a 20190104133721 $b ABA008
- 999 __
- $a ok $b bmc $g 1192618 $s 966782
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2016 $b 160 $c 1 $d 149-152 $e 20160203 $i 1213-8118 $m Biomedical papers of the Medical Faculty of the University Palacký, Olomouc Czech Republic $n Biomed. Pap. Fac. Med. Palacký Univ. Olomouc Czech Repub. (Print) $x MED00012606
- GRA __
- $a NT14361 $p MZ0
- LZP __
- $b NLK118 $a Pubmed-20170210